Brinda K Navalgund, M.D. Pain Medicine - Pain Medicine Medicare: Medicare Enrolled Practice Location: 1275 S Main St, Suite 103, Greensburg, PA 15601 Phone: 412-561-7246 Fax: 412-235-4011 |
Thomas Lynn Whitten, M.D. Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 4893 State Route 30, Suite8, Greensburg, PA 15601 Phone: 724-600-0607 Fax: 724-600-0608 |
Dr. Yeshvant A Navalgund, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Village Dr, Greensburg, PA 15601 Phone: 412-561-7246 Fax: 866-580-7246 |
News Archive
Scientists from Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology have used the power of new genomic technology to discover that microbes that commonly infect the eye have special, previously unknown properties. These properties are predicted to allow the bacterium - Streptococcus pneumoniae - to specifically stick to the surface of the eye, grow, and cause damage and inflammation.
A University of Michigan cell biologist and his colleagues have identified a potential drug that speeds up trash removal from the cell's recycling center, the lysosome.
Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.
An international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are getting together to set how gene therapies in hemophilia should be measured for effectiveness.
The following quote is attributed to Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health.
› Verified 4 days ago